期刊文献+

Successful percutaneous coronary intervention reduces plasma concentration of NT-proBNP in patients with coronary heart disease and normal ventricular function 被引量:1

Successful percutaneous coronary intervention reduces plasma concentration of NT-proBNP in patients with coronary heart disease and normal ventricular function
原文传递
导出
摘要 Background To the effect of percutaneous coronary intervention (PCI) on plasma level of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with coronary heart disease (CHD) and normal left ventricular function. Methods One hundred and five patients with CHD and normal ventricular function were enrolled. Blood samples for assessment of NT-proBNP and cTn-T were collected before and after PCI. Results The mean left ventricular ejection fraction was 60.3 ± 5.3%. After revascularization, the level of lgNT-proBNP was signifi-cantly reduced (2.40 ± 0.44 vs 2.23± 0.43, P 〈 0.001). Subgroup analysis showed that the level of lgNT-proB-NP ws consistently decreased in different clinical classifications (stable angina: 45, unstable angina: 31 and acute myocardial infarction: 29) and target-vessel revascularization (left anterior descending artery: 30, left cir-cumflex artery: 26 and right coronary artery: 49), and in 99 patients without elevation of post-procedural cTn- T, but it showed a trend of non-significant increase in 6 patients with elevated cTn-T. Conclusions Our study demonstrates that successful PCI reduces plasma NT-proBNP concentration in patients with CHD and normal ven-tricular function. This implicates that the impact of PCI should be considered in the interpretation of NT-proBNP change in clinical practice, and further studies are necessary to investigate the direct and/or indirect effect of myocardial ischemia on BNP/NT-proBNP. Background To the effect of percutaneous coronary intervention (PCI) on plasma level of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with coronary heart disease (CHD) and normal left ventricular function. Methods One hundred and five patients with CHD and normal ventricular function were enrolled. Blood samples for assessment of NT-proBNP and cTn-T were collected before and after PCI. Results The mean left ventricular ejection fraction was 60.3 ± 5.3%. After revascularization, the level of lgNT-proBNP was signifi-cantly reduced (2.40 ± 0.44 vs 2.23± 0.43, P 〈 0.001). Subgroup analysis showed that the level of lgNT-proB-NP ws consistently decreased in different clinical classifications (stable angina: 45, unstable angina: 31 and acute myocardial infarction: 29) and target-vessel revascularization (left anterior descending artery: 30, left cir-cumflex artery: 26 and right coronary artery: 49), and in 99 patients without elevation of post-procedural cTn- T, but it showed a trend of non-significant increase in 6 patients with elevated cTn-T. Conclusions Our study demonstrates that successful PCI reduces plasma NT-proBNP concentration in patients with CHD and normal ven-tricular function. This implicates that the impact of PCI should be considered in the interpretation of NT-proBNP change in clinical practice, and further studies are necessary to investigate the direct and/or indirect effect of myocardial ischemia on BNP/NT-proBNP.
出处 《South China Journal of Cardiology》 CAS 2012年第3期161-168,共8页 岭南心血管病杂志(英文版)
关键词 natriuretic peptide coronary artery disease percutaneous transluminal coronary angioplasty is-chemia natriuretic peptide coronary artery disease percutaneous transluminal coronary angioplasty is-chemia
  • 相关文献

参考文献10

  • 1Yasue H,Yoshimura M,Sumida H,et al.Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure[].Circulation.1994
  • 2Maeda K,Takayoshi T,Wada A,et al.Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction[].American Heart Journal.1998
  • 3Goetze JP,Christoffersen C,Perko M,et al.Increased cardiac BNP expression associated with myocardial ischemia[].FASEB Journal The.2003
  • 4Hama N,Itoh H,Shirakami G,et al.Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction[].Circulation.1995
  • 5Suzuki T,Yamazaki T,Yazaki Y.The role of the natriuretic peptides in the cardiovascular system[].Cardiovascular Research.2001
  • 6Sabatine MS,Morrow DA,de Lemos JA,et al.Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia[].Journal of the American College of Cardiology.2004
  • 7Mueller C,Scholer A,Laule-Kilian K,et al.Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea[].New England Journal of Medicine The.2004
  • 8de Lemos JA,Morrow DA,Bentley JH,et al.The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes[].New England Journal of Homeopathy.2001
  • 9Cantor W J,Newby L K,Christenson R H,et al.Prognostic significance of elevated troponin I after percutaneous coronary intervention[].Journal of the American College of Cardiology.2002
  • 10Tateishi J,Masutani M,Ohyanagi M,et al.Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty[].Clinical Cardiology.2000

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部